N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide

C86H167F3N14O11 — CID 167585094

IUPACN-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide
SMILESCC(C)C(=O)NC1(COCCN2CCOCC2)CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CO)CCN(C(C)C)CC1.CC(C)CC(=O)NC1CCN(C(C)C)CC1N.CC(C)CC(=O)NC1CCN(C(C)C)CC1O.CC(C)N1CCC(C)(NC(=O)C2(C)CCC2)CC1.CC(C)N1CCC(NC(=O)CCC(F)(F)F)C(O)C1
InChIInChI=1S/C19H37N3O3.C15H28N2O.C14H28N2O2.C13H27N3O.C13H26N2O2.C12H21F3N2O2/c1-16(2)18(23)20-19(5-7-22(8-6-19)17(3)4)15-25-14-11-21-9-12-24-13-10-21;1-12(2)17-10-8-15(4,9-11-17)16-13(18)14(3)6-5-7-14;1-11(2)9-13(18)15-14(10-17)5-7-16(8-6-14)12(3)4;1-9(2)7-13(17)15-12-5-6-16(10(3)4)8-11(12)14;1-9(2)7-13(17)14-11-5-6-15(10(3)4)8-12(11)16;1-8(2)17-6-4-9(10(18)7-17)16-11(19)3-5-12(13,14)15/h16-17H,5-15H2,1-4H3,(H,20,23);12H,5-11H2,1-4H3,(H,16,18);11-12,17H,5-10H2,1-4H3,(H,15,18);9-12H,5-8,14H2,1-4H3,(H,15,17);9-12,16H,5-8H2,1-4H3,(H,14,17);8-10,18H,3-7H2,1-2H3,(H,16,19)
InChIKeyHRSBMYKDZHSUKW-UHFFFAOYSA-N
MW1630.36 g/mol
LogP8.53
Rot. Bonds28

About N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide

N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide (PubChem CID 167585094) has the molecular formula C86H167F3N14O11 and a molecular weight of 1630.36 g/mol. Its IUPAC name is N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide.

Molecular Properties

Compound NameN-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide
PubChem CID167585094
Molecular FormulaC86H167F3N14O11
Molecular Weight1630.36 g/mol
Exact Mass1629.29
IUPAC NameN-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide
SMILESCC(C)C(=O)NC1(COCCN2CCOCC2)CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CO)CCN(C(C)C)CC1.CC(C)CC(=O)NC1CCN(C(C)C)CC1N.CC(C)CC(=O)NC1CCN(C(C)C)CC1O.CC(C)N1CCC(C)(NC(=O)C2(C)CCC2)CC1.CC(C)N1CCC(NC(=O)CCC(F)(F)F)C(O)C1
InChIInChI=1S/C19H37N3O3.C15H28N2O.C14H28N2O2.C13H27N3O.C13H26N2O2.C12H21F3N2O2/c1-16(2)18(23)20-19(5-7-22(8-6-19)17(3)4)15-25-14-11-21-9-12-24-13-10-21;1-12(2)17-10-8-15(4,9-11-17)16-13(18)14(3)6-5-7-14;1-11(2)9-13(18)15-14(10-17)5-7-16(8-6-14)12(3)4;1-9(2)7-13(17)15-12-5-6-16(10(3)4)8-11(12)14;1-9(2)7-13(17)14-11-5-6-15(10(3)4)8-12(11)16;1-8(2)17-6-4-9(10(18)7-17)16-11(19)3-5-12(13,14)15/h16-17H,5-15H2,1-4H3,(H,20,23);12H,5-11H2,1-4H3,(H,16,18);11-12,17H,5-10H2,1-4H3,(H,15,18);9-12H,5-8,14H2,1-4H3,(H,15,17);9-12,16H,5-8H2,1-4H3,(H,14,17);8-10,18H,3-7H2,1-2H3,(H,16,19)
InChIKeyHRSBMYKDZHSUKW-UHFFFAOYSA-N
XLogP8.53
TPSA302.45 Ų
H-Bond Donors10
H-Bond Acceptors19
Rotatable Bonds28
Heavy Atoms114
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001630.36
LogP ≤ 58.53
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1019

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide?
The IUPAC name of N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide (CID 167585094) is N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide.
What is the SMILES notation for N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide?
The canonical SMILES for N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide is CC(C)C(=O)NC1(COCCN2CCOCC2)CCN(C(C)C)CC1.CC(C)CC(=O)NC1(CO)CCN(C(C)C)CC1.CC(C)CC(=O)NC1CCN(C(C)C)CC1N.CC(C)CC(=O)NC1CCN(C(C)C)CC1O.CC(C)N1CCC(C)(NC(=O)C2(C)CCC2)CC1.CC(C)N1CCC(NC(=O)CCC(F)(F)F)C(O)C1.
What is the InChIKey of N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide?
The InChIKey is HRSBMYKDZHSUKW-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H37N3O3.C15H28N2O.C14H28N2O2.C13H27N3O.C13H26N2O2.C12H21F3N2O2/c1-16(2)18(23)20-19(5-7-22(8-6-19)17(3)4)15-25-14-11-21-9-12-24-13-10-21;1-12(2)17-10-8-15(4,9-11-17)16-13(18)14(3)6-5-7-14;1-11(2)9-13(18)15-14(10-17)5-7-16(8-6-14)12(3)4;1-9(2)7-13(17)15-12-5-6-16(10(3)4)8-11(12)14;1-9(2)7-13(17)14-11-5-6-15(10(3)4)8-12(11)16;1-8(2)17-6-4-9(10(18)7-17)16-11(19)3-5-12(13,14)15/h16-17H,5-15H2,1-4H3,(H,20,23);12H,5-11H2,1-4H3,(H,16,18);11-12,17H,5-10H2,1-4H3,(H,15,18);9-12H,5-8,14H2,1-4H3,(H,15,17);9-12,16H,5-8H2,1-4H3,(H,14,17);8-10,18H,3-7H2,1-2H3,(H,16,19).
What are the key properties of N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide?
N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide has a molecular weight of 1630.36 g/mol, XLogP of 8.53, 28 rotatable bonds, 10 hydrogen bond donors, and 19 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3-amino-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;N-[4-(hydroxymethyl)-1-propan-2-ylpiperidin-4-yl]-3-methylbutanamide;N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)-3-methylbutanamide;1-methyl-N-(4-methyl-1-propan-2-ylpiperidin-4-yl)cyclobutane-1-carboxamide;2-methyl-N-[4-(2-morpholin-4-ylethoxymethyl)-1-propan-2-ylpiperidin-4-yl]propanamide;4,4,4-trifluoro-N-(3-hydroxy-1-propan-2-ylpiperidin-4-yl)butanamide is sourced from PubChem (CID 167585094), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).